Under in vitro induction conditions, the erythroid differentiation pattern of PV patient BM-MNCs showed no difference compared to healthy controls as indicated by the percentages of CD71+ and CD235a+ cells (Fig. 1G). The gene discussed is TFRC; the disease is acquired polycythemia vera.